Penn Medicine Co-Investment Program Investor
Penn Medicine Co-Investment Program invests in cell therapy, gene therapy, mRNA, lipid nanoparticle, and connected health spinouts from Penn
Technology:
Cell_Therapies
Headquarters:
Philadelphia, Pennsylvania, United States
Employees Number:
10001+
Investor Type:
Venture Capital
Investment Stage:
Convertible Note, Early Stage Venture, Late Stage Venture, Seed, Venture
Number Of Exits:
3
Register and Claim Ownership